Heckler - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Heckler

Showing results (381-390 of 383) with videos related to

Pageof 39

Sort By:

You have reached the last page of results.This site can display upto 383 results.

Science Translational Medicine|May 20, 2021

cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytesKevin Roehle, Li Qiang, Katherine S Ventre, et al.

Gastroenterology|July 5, 2023

Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for DiscontinuationGiovanni Marchegiani, Tommaso Pollini, Anna Burelli, et al.

Nature Cancer|April 26, 2021

EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.

Pageof 39

Search research articles

Showing results (381-390 of 383) with videos related to

Sort By:

Pageof 39

You have reached the last page of results.This site can display upto 383 results.

Science Translational Medicine|May 20, 2021

cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytesKevin Roehle, Li Qiang, Katherine S Ventre, et al.

Gastroenterology|July 5, 2023

Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for DiscontinuationGiovanni Marchegiani, Tommaso Pollini, Anna Burelli, et al.

Nature Cancer|April 26, 2021

EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.

Pageof 39